Breaking News Instant updates and real-time market news.

CQP

Cheniere Energy Partners

$39.40

-0.11 (-0.28%)

, LONG

eLong

$0.00

(0.00%)

04:55
10/05/18
10/05
04:55
10/05/18
04:55

Wells Fargo to hold a field trip

7th Annual WFC London LNG & Shipping Field Trip will travel through London, England on October 1-5.

CQP

Cheniere Energy Partners

$39.40

-0.11 (-0.28%)

LONG

eLong

$0.00

(0.00%)

GLNG

Golar LNG

$27.53

-0.57 (-2.03%)

GMLP

Golar LNG Partners

$14.51

-0.2 (-1.36%)

LNG

Cheniere Energy

$67.55

-1.3 (-1.89%)

GLOG

GasLog

$19.99

-0.43 (-2.11%)

GLOP

GasLog Partners

$25.30

-0.14 (-0.55%)

EURN

Euronav NV

$9.22

0.09 (0.99%)

FRO

Frontline

$6.41

-0.065 (-1.00%)

FLEX

Flex

$12.65

-0.19 (-1.48%)

SDRL

Seadrill

$24.66

-1.14 (-4.42%)

NVGS

Navigator Holdings

$12.05

-0.14 (-1.15%)

DHT

DHT Holdings

$4.96

0.05 (1.02%)

STNG

Scorpio Tankers

$2.07

-0.07 (-3.28%)

SALT

Scorpio Bulkers

$7.35

0.09 (1.24%)

ASC

Ardmore Shipping

$6.94

-0.3 (-4.14%)

  • 09

    Oct

  • 25

    Oct

CQP Cheniere Energy Partners
$39.40

-0.11 (-0.28%)

03/26/18
BERN
03/26/18
UPGRADE
BERN
Outperform
Cheniere Energy Partners upgraded to Outperform from Market Perform at Bernstein
08/24/18
USCA
08/24/18
DOWNGRADE
Target $40
USCA
Hold
Cheniere Energy Partners downgraded to Hold from Overweight at US Capital
US Capital Advisors analyst Rebecca Followill downgraded Cheniere Energy Partners to Hold while raising her price target for the shares to $40 from $35.
07/05/18
LEHM
07/05/18
NO CHANGE
Target $77
LEHM
Overweight
Cheniere Energy price target raised to $77 from $65 at Barclays
Barclays analyst Christine Cho raised her price target for Cheniere Energy (LNG) to $77 and keeps an Overweight rating on the shares. She also raised her price target for Equal Weight-rated Cheniere Energy Partners (CQP) to $38 from $35 and Equal Weight-rated Cheniere Energy Partners LP (CQH) to $37 from $32. Cho estimates the combination of Train 6 and Cheniere Energy Partners' buy-in will add $440 in discounted cash flow to Cheniere Energy on a pre-tax basis. At a 7.5% discounted cash flow yield, the analyst estimates this equates to about $20 per Cheniere Energy share on an undiscounted basis. She thinks the stock could trade to $100 as 2024 approaches, all else being equal.
08/13/18
WELS
08/13/18
NO CHANGE
Target $45
WELS
Outperform
Cheniere Energy Partners price target raised to $45 from $40 at Wells Fargo
Wells Fargo analyst Michael Webber raised his price target for Cheniere Energy Partners to $45 from $40, while reiterating an Outperform rating on the shares. Despite the softer Q2 results, the analyst believes it remains the most liquid and best positioned LNG export names. While Webber thinks tariff headwinds likely weigh on near-term sentiment, Cheniere's valuation, CF growth, and underlying quality keep him a buyer of the stock.
LONG eLong
$0.00

(0.00%)

GLNG Golar LNG
$27.53

-0.57 (-2.03%)

10/03/18
RILY
10/03/18
INITIATION
Target $34
RILY
Buy
Golar LNG initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Liam Burke started Golar LNG Limited withe a Buy rating and $34 price target.
08/22/18
JEFF
08/22/18
NO CHANGE
Target $40
JEFF
Buy
Golar LNG pullback brings 'extremely attractive' opportunity, says Jefferies
The recent pullback in shares of Golar LNG brings an "extremely attractive buying opportunity," Jefferies analyst Randy Giveans tells investors in a research note titled "When It Comes To Golar LNG, We Have Good News And We Have ... More Good News." The liquefied natural gas market is "very strong" and set to improve further in the coming months while Golar LNG's non-shipping projects are progressing nicely, Giveans adds. The analyst attributes the stock's selloff to U.S.-China trade tensions and the drop in the price of Brent crude. He keeps a Buy rating on Golar LNG with a $40 price target.
07/18/18
BTIG
07/18/18
INITIATION
Target $23
BTIG
Buy
GasLog, GolarLNG initiated with a Buy at BTIG
BTIG analyst Gregory Lewis initiated GasLog (GLOG) and Golar LNG (GLNG) with a Buy rating and respective $23 and $35 price targets as part of his broader launch of coverage on the LNG shipping industry. Lewis says he is bullish on the LNG shipping trends over the medium term and expects average prices to move above mid-cycle levels over the next two years thanks to the spike in shipping rates in a tight market. The analyst further notes that "increasing liquefaction capacity growth of about 10% annually through 2020 will drive increased demand for seaborne LNG. Lewis also initiates GasLog Partners (GLOP) at a Buy with a $30 price target based on its "identifiable growth pipeline which should drive distribution growth higher", and also starts Golar LNG Partners (GMLP) and Hoegh LNG (HMLP) at Neutral given their low distribution rates.
07/12/18
07/12/18
DOWNGRADE
Target $30

Neutral
Golar LNG downgraded to Neutral at BofA/Merrill
As previously reported, BofA/Merrill downgraded Golar LNG to Neutral from Buy and trimmed its price target to $30 from $31. Analyst Ken Hoexter said LNGC rates have accelerated this quarter attracting new entrants and supply and revised hi sum of the parts valuation given delays in executing the Fortuna project and high debt burden.
GMLP Golar LNG Partners
$14.51

-0.2 (-1.36%)

06/27/18
JEFF
06/27/18
NO CHANGE
Target $40
JEFF
Buy
Golar LNG added to Franchise Picks list at Jefferies
Jefferies analyst Randy Giveans added Golar LNG (GLNG) to the firm's Franchise Picks list citing the rapidly improving LNG shipping market and the upcoming partial dropdown of the Hilli FLNG project to Golar LNG Partners (GMLP), which he views as likely only days away. The project, which marks the first successful conversion of an LNG carrier to an FLNG vessel, is a "significant milestone" and Golar LNG has several other catalysts on the horizon, Giveans tells investors. He has a $40 price target on Golar LNG shares.
09/05/18
DNBM
09/05/18
DOWNGRADE
DNBM
Sell
Golar LNG Partners downgraded to Sell from Hold at DNB Markets
09/05/18
RILY
09/05/18
INITIATION
Target $17
RILY
Neutral
Golar LNG Partners resumed with a Neutral at B. Riley FBR
B. Riley FBR analyst Liam Burke resumed coverage of Golar LNG Partners with a Neutral rating and $17 price target.
LNG Cheniere Energy
$67.55

-1.3 (-1.89%)

09/26/18
MSCO
09/26/18
UPGRADE
MSCO
Overweight
Cheniere Energy upgraded to Overweight from Equal Weight at Morgan Stanley
09/26/18
09/26/18
UPGRADE
Target $80

Overweight
Cheniere Energy upgraded to Overweight on LNG demand growth at Morgan Stanley
As previously reported, Morgan Stanley analyst Fotis Giannakoulis upgraded Cheniere Energy to Overweight from Equal Weight citing the rapid increase in global LNG demand, mainly driven by China. Trade tensions between the U.S. and China may increase the barrier to entry for competitors, benefitting established producers like Cheniere, Giannakoulis added. The analyst, who expects Cheniere will continue to add capacity, raised his price target on the stock to $80 from $63 to now include the addition of train 6 at Sabine Pass.
09/26/18
COWN
09/26/18
UPGRADE
Target $76
COWN
Outperform
Cheniere Energy upgraded to Outperform from Market Perform at Cowen
Cowen analyst Jason Gabelman upgraded Cheniere Energy to Outperform from Market Perform as he favors companies with existing operations because he expects LNG demand growth to 2025 to be supplied primarily from integrated oil companies' projects and companies with proven track records. Gabelman has a $76 price target on Cheniere Energy shares.
09/26/18
09/26/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Viacom (VIAB) upgraded to Buy from Neutral at B. Riley FBR. 2. GoPro (GPRO) upgraded to Outperform from Perform at Oppenheimer with analyst Andrew Uerkwitz saying he believes the company has done everything it can to position itself for success. 3. STMicroelectronics (STM) upgraded to Buy from Hold at Deutsche Bank with analyst Johannes Schaller saying the stock has "suffered too much," setting up for an attractive risk/reward profile at current levels. 4. IBM (IBM) upgraded to Buy from Neutral at UBS with analyst John Roy saying the market is pricing in a 2% revenue decline, which IBM can beat. 5. Cheniere Energy (LNG) upgraded to Overweight from Equal Weight at Morgan Stanley and to Outperform from Market Perform at Cowen. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GLOG GasLog
$19.99

-0.43 (-2.11%)

09/05/18
DNBM
09/05/18
UPGRADE
DNBM
Buy
GasLog upgraded to Buy from Hold at DNB Markets
09/05/18
09/05/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Anthem (ANTM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Zack Sopcak saying he contends that the disruption in the pharmacy benefits management landscape via M&A and government-led drug pricing reform positions Anthem for underappreciated share gain and accelerated profit growth. 2. BP (BP) upgraded to Overweight from Equal Weight at Morgan Stanley. 3. GasLog (GLOG) upgraded to Buy from Hold at DNB Markets. 4. CenterPoint Energy (CNP) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Turnure saying he sees an "attractive outlook for the proforma company" with 8.2% annual earnings growth through 2021 "under a conservative range of assumptions." 5. PerkinElmer (PKI) upgraded to Equal Weight from Underweight at Barclays with analyst Jack Meehan saying he is more positive on PerkinElmer's near-term growth prospects in Diagnostics due to its recent investments. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/24/18
MSCO
08/24/18
UPGRADE
MSCO
Overweight
GasLog upgraded to Overweight from Equal Weight at Morgan Stanley
08/09/18
08/09/18
UPGRADE
Target $22

Overweight
GasLog upgraded to Overweight on tighter LNG shipping market at Morgan Stanley
As previously reported, Morgan Stanley analyst Fotis Giannakoulis upgraded GasLog to Overweight from Equal Weight, noting that the LNG shipping market is rapidly tightening and stating that he expects GasLog's leading position should allow it to outgrow its peers. He also sees global demand exceeding expectations, driven by China's environmental initiatives. Giannakoulis raised his price target on GasLog shares to $22 from $20.
GLOP GasLog Partners
$25.30

-0.14 (-0.55%)

09/05/18
RILY
09/05/18
INITIATION
Target $27
RILY
Neutral
GasLog Partners resumed with a Neutral at B. Riley FBR
B. Riley FBR analyst Liam Burke resumed coverage of GasLog Partners with a Neutral rating and $27 price target.
12/18/17
JEFF
12/18/17
INITIATION
Target $28
JEFF
Buy
GasLog Partners assumed with a Buy at Jefferies
Jefferies analyst Randy Giveans assumed coverage of GasLog Partners with a Buy rating and $28 price target. The analyst assumed coverage of 23 energy maritime shipping names saying the industry is "primed for significant improvement." For the first time in 10 years, the analyst expects capacity shortages with demand growth to outpace supply growth in every shipping sector in 2018.
05/17/18
RILY
05/17/18
INITIATION
Target $26
RILY
Neutral
GasLog Partners initiated with a Neutral at B. Riley FBR
B. Riley FBR analyst Robert Balsamo started GasLog Partners with a Neutral rating and $26 price target.
EURN Euronav NV
$9.22

0.09 (0.99%)

03/06/18
DNBM
03/06/18
UPGRADE
DNBM
Buy
Euronav NV upgraded to Buy from Hold at DNB Markets
09/27/18
BTIG
09/27/18
INITIATION
Target $12
BTIG
Buy
Euronav NV initiated with a Buy at BTIG
BTIG analyst Gregory Lewis initiated Euronav with a Buy rating and a price target of $12 as part of his broader research note on oil tankers. He calls the company an "800 pound gorilla" in the crude tanker market that will go "on a rampage" when crude tanker fundamentals improve. The analyst cites the company's "leverage to the spot market" and "best in class balance sheet", adding that the "Very Large Crude Carrier", or VLCC, rate have been on pace for their worst year ever but stand to raise 50%-60% in 2019.
10/01/18
JEFF
10/01/18
INITIATION
Target $11
JEFF
Buy
Euronav NV initiated with a Buy at Jefferies
Jefferies analyst Randy Giveans started Euronav NV with a Buy rating and $11 price target. Tanker demand growth is set to outpace tanker supply growth through at least 2020, Giveans tells investors in a research note. As a result. he believes the crude tanker market is now past the bottom and shipping rates should improve significantly in the coming quarters and years.
08/14/18
PART
08/14/18
UPGRADE
PART
Buy
Euronav NV upgraded to Buy from Hold at Pareto
FRO Frontline
$6.41

-0.065 (-1.00%)

03/06/18
DNBM
03/06/18
UPGRADE
DNBM
Buy
Frontline upgraded to Buy from Hold at DNB Markets
10/01/18
JEFF
10/01/18
INITIATION
Target $6
JEFF
Hold
Frontline initiated with a Hold at Jefferies
Jefferies analyst Randy Giveans started Frontline with a Hold rating and $6 price target. Tanker demand growth is set to outpace tanker supply growth through at least 2020, Giveans tells investors in a research note. As a result. he believes the crude tanker market is now past the bottom and shipping rates should improve significantly in the coming quarters and years.
09/27/18
BTIG
09/27/18
INITIATION
BTIG
Neutral
Frontline initiated with a Neutral at BTIG
BTIG analyst Gregory Lewis initiated Frontline with a Neutral rating as part of his broader research note on oil tankers. The analyst says the company has been one of the best tanker stocks this year, rising 12% while its peer group fell 12%. Though he sees the stock as a "beta play" to tanker recovery, Lewis believes that recovery is still a few quarters away. The analyst also points to Frontline's stretched valuation of 1.6-times price to net asset value and models its FY19 EBITDA at $237M - below consensus of $260M.
06/18/18
WELS
06/18/18
UPGRADE
Target $7
WELS
Outperform
Frontline upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Michael Webber upgraded Frontline to Outperform and raised his price target for the shares to $7 from $5.30. The analyst believes the Tanker group is "uniquely positioned" to benefit from both a likely OPEC production increase in June and "potentially significant" IMO 2020 tailwinds. IMO 2020-driven ton-mile and floating storage catalysts could create a "thematic bid for the sector," with near-trough level net asset values helping to limit downside risks, Webber tells investors in a research note.
FLEX Flex
$12.65

-0.19 (-1.48%)

04/27/18
SBSH
04/27/18
NO CHANGE
Target $16
SBSH
Buy
Flex earnings selloff brings buying opportunity, says Citi
Flex's (FLEX) March quarter results were filled with several items that will be viewed by investors as bad news, including a delay in profitability ramp from Nike (NKE) and an unrelated accounting investigation resulting in the stock trading down 15% after hours, Citi analyst Jim Suva tells investors in a research note. The analyst believes the stock pressure is warranted following the 25% gain last year, but does not think these items are a "structural flaw to the company's operations or cash flows." As such, Suva views today's stock pullback as a buying opportunity. The Nike issue should be fully resolved within six months and the accounting investigation appears limited, he argues. The analyst lowered his price target for Flex to $16 from $20 and keeps a Buy rating on the name.
05/11/18
UBSW
05/11/18
NO CHANGE
Target $18
UBSW
Buy
Flex near-term may be pressured but long-term better, says UBS
UBS analyst Steven Milunovich said Flex boosted its capital expenditure guidance, which may pressure the shares in the near-term as the company ramps up its investment. The analyst noted bookings were strong across the board and guidance was unchanged, giving him confidence in the longer-term outlook for the shares. Milunovich reiterated his Buy rating and $18 price target on Flex shares.
06/18/18
STPT
06/18/18
UPGRADE
STPT
Buy
Flex upgraded to Buy from Hold at Standpoint Research
04/27/18
04/27/18
DOWNGRADE

Market Perform
Flex downgraded to Market Perform, growth pushed out at Raymond James
As previously reported, Raymond James downgraded Flex two notches to Market Perform from Strong Buy following Q4 results. Analyst Adam Tindle said the outsized profit growth he expected in FY19 appears to be back half weighted, at best. Tindle would wait for better visibility into CEC growth, profitability with Nike, and improved utilization in broader CTG before becoming constructive on shares.
SDRL Seadrill
$24.66

-1.14 (-4.42%)

06/01/18
GHSC
06/01/18
UPGRADE
Target $18
GHSC
Buy
Ship Finance upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Magnus Fyhr upgraded Ship Finance (SFL) to Buy with a $18 price target saying risk/reward is increasingly attractive with several potential catalysts developing over the next few months, combined with the Seadrill (SDRL) restructuring already reflected in estimates. Fyhr said the company has ample dry powder to pursue accretive acquisitions and the current backlog provides cash flow visibility and dividend support.
NVGS Navigator Holdings
$12.05

-0.14 (-1.15%)

02/12/18
MSCO
02/12/18
UPGRADE
MSCO
Equal Weight
Navigator Holdings upgraded to Equal Weight from Underweight at Morgan Stanley
02/12/18
02/12/18
UPGRADE
Target $12.5

Equal Weight
Navigator Holdings upgraded to Equal Weight at Morgan Stanley
As previously reported, Morgan Stanley analyst Fotis Giannakoulis upgraded Navigator Holdings to Equal Weight from Underweight and increased his price target on the stock to $12.50 from $8 citing improving gas trade fundamentals. Giannakoulis expects the freight rates for LPG and petchem gases strengthen the next three years driven by higher U.S. exports, strong Asian retail demand and a slowdown in fleet supply growth, he tells investors.
12/18/17
JEFF
12/18/17
INITIATION
Target $15
JEFF
Buy
Navigator Holdings assumed with a Buy at Jefferies
Jefferies analyst Randy Giveans assumed coverage of Navigator Holdings with a Buy rating and $15 price target. The analyst assumed coverage of 23 energy maritime shipping names saying the industry is "primed for significant improvement." For the first time in 10 years, the analyst expects capacity shortages with demand growth to outpace supply growth in every shipping sector in 2018.
DHT DHT Holdings
$4.96

0.05 (1.02%)

06/18/18
WELS
06/18/18
UPGRADE
WELS
Outperform
DHT Holdings upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Michael Webber upgraded DHT Holdings to Outperform and raised his price target for the shares to $7 from $5. The analyst believes the Tanker group is "uniquely positioned" to benefit from both a likely OPEC production increase in June and "potentially significant" IMO 2020 tailwinds. IMO 2020-driven ton-mile and floating storage catalysts could create a "thematic bid for the sector," with near-trough level net asset values helping to limit downside risks, Webber tells investors in a research note.
08/14/18
PART
08/14/18
DOWNGRADE
PART
Hold
DHT Holdings downgraded to Hold from Buy at Pareto
07/24/18
EVER
07/24/18
DOWNGRADE
EVER
In Line
DHT Holdings downgraded to In Line from Outperform at Evercore ISI
04/20/18
04/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Neutral from Buy at BofA/Merrill and to Hold from Buy at Deutsche Bank aw well as Argus. 2. Philip Morris (PM) downgraded to Buy from Conviction Buy at Goldman Sachs and to Underperform from Neutral at BofA/Merrill. 3. DHT Holdings (DHT) downgraded to Neutral from Overweight at JPMorgan with analyst Noah Parquette saying he has become more constructive on a crude tanker recovery in 2019 but cites relative valuation for the downgrade on DHT. 4. Skechers (SKX) downgraded to Neutral from Outperform at Wedbush with analyst Christopher Svezia citing the company's first quarter results. 5. Tyson Foods (TSN) downgraded to Hold from Buy at Vertical Group. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
STNG Scorpio Tankers
$2.07

-0.07 (-3.28%)

04/10/18
DBAB
04/10/18
NO CHANGE
DBAB
Buy
Scorpio Tankers pullback offers 'major opportunity,' says Deutsche Bank
Deutsche Bank analyst Amit Mehrotra sees a "major opportunity" in shares of Scorpio Tankers with the stock down 38% year-to-date. Market participants are "rightfully concerned" about the expected step-function increase in cash calls related to debt repayments, Mehrotra tells investors in a research note. The negative implication is that Scorpio will have to do a highly dilutive equity offering to meet increasing cash flows, the analyst adds. However, his analysis implies "significant dislocation" if management is able to extend its run-way, which he believes is "highly probable." Mehrotra keeps a Buy rating on Scorpio Tankers.
09/27/18
BTIG
09/27/18
INITIATION
Target $3
BTIG
Buy
Scorpio Tankers initiated with a Buy at BTIG
BTIG analyst Gregory Lewis initiated Scorpio Tankers with a Buy rating and a price target of $3 as part of his broader research note on oil tankers. The analyst notes that after a "tough summer" that saw the company's stock price fall 30% because of "lousy charter rates and a stretched balance sheet", its prospects are looking up. Lewis points to a "thawing" in the medium range, or MR, tanker rates, which he expects to rise by up to 20% in 2019. The analyst is also positive on Scorpio Tankers' capacity as the "largest product tanker operator in the world with 109 owned ships", adding that in the near term, the company should focus on paying down its debt.
12/18/17
JEFF
12/18/17
INITIATION
Target $5
JEFF
Buy
Scorpio Tankers assumed with a Buy at Jefferies
Jefferies analyst Randy Giveans assumed coverage of Scorpio Tankers with a Buy rating and $5 price target. The analyst assumed coverage of 23 energy maritime shipping names saying the industry is "primed for significant improvement." For the first time in 10 years, the analyst expects capacity shortages with demand growth to outpace supply growth in every shipping sector in 2018.
04/25/18
DNBM
04/25/18
UPGRADE
DNBM
Buy
Scorpio Tankers upgraded to Buy from Hold at DNB Markets
DNB Markets analyst Nicolay Dyvik upgraded Scorpio Tankers to Buy from Hold.
SALT Scorpio Bulkers
$7.35

0.09 (1.24%)

04/23/18
STFL
04/23/18
UPGRADE
Target $9
STFL
Buy
Scorpio Bulkers upgraded to Buy from Hold at Stifel
Stifel analyst Benjamin Nolan upgraded Scorpio Bulkers to Buy from Hold as he believes the shares but have sufficient upside potential to warrant buying at current levels given their 25% discount to his NAV estimate and his belief that the dry bulk shipping market is positioned for profitability and modest further improvements. He has a $9 price target on Scorpio Bulkers shares.
10/03/18
RILY
10/03/18
INITIATION
Target $9.5
RILY
Buy
Scorpio Bulkers initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Liam Burke started Scorpio Bulkers with a Buy rating and $9.50 price target.
01/12/18
NBLE
01/12/18
INITIATION
Target $10
NBLE
Buy
Scorpio Bulkers initiated with a Buy at Noble Financial
Noble initiated Scorpio Bulkers with a Buy and $10 price target.
12/18/17
JEFF
12/18/17
INITIATION
Target $14
JEFF
Buy
Scorpio Bulkers assumed with a Buy at Jefferies
Jefferies analyst Randy Giveans assumed coverage of Scorpio Bulkers with a Buy rating and $14 price target. The analyst assumed coverage of 23 energy maritime shipping names saying the industry is "primed for significant improvement." For the first time in 10 years, the analyst expects capacity shortages with demand growth to outpace supply growth in every shipping sector in 2018.
ASC Ardmore Shipping
$6.94

-0.3 (-4.14%)

12/18/17
JEFF
12/18/17
INITIATION
Target $11
JEFF
Buy
Ardmore Shipping assumed with a Buy at Jefferies
Jefferies analyst Randy Giveans assumed coverage of Ardmore Shipping with a Buy rating and $11 price target. The analyst assumed coverage of 23 energy maritime shipping names saying the industry is "primed for significant improvement." For the first time in 10 years, the analyst expects capacity shortages with demand growth to outpace supply growth in every shipping sector in 2018.
04/20/18
JPMS
04/20/18
UPGRADE
Target $6
JPMS
Overweight
Navios Maritime Midstream upgraded to Overweight from Underweight at JPMorgan
JPMorgan analyst Noah Parquette double upgraded Navios Maritime Midstream to Overweight from Underweight while lowering his price target for the shares to $6 from $7. Following the stock decline on the distribution cut, Navios Maritime Midstream joins International Seaways (INSW) as Parquette's favorite way to play a potential crude tanker recovery. Ardmore Shipping (ASC) remains his top pick in product tankers. The analyst has become more constructive on a crude tanker recovery in 2019.
09/25/18
09/25/18
UPGRADE

Ardmore Shipping upgraded to Buy from Reduce at Fearnley
Fearnley Securities analyst Peder Jarlsby upgraded Ardmore Shipping to Buy from Reduce and raised his price target for the shares to $9.30 from $6.70. With the inventory draw cycle coming to an end and oil production growth picking up, the analyst believes an inflection point will hit the product market in Q4.
01/19/18
JPMS
01/19/18
DOWNGRADE
JPMS
Neutral
Navios Acquisition downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Noah Parquette downgraded Navios Maritime Acquisition (NNA) to Neutral on concerns the dividend could be cut if his rate forecasts prove to be correct. He believes 2018 could be a tough year for crude tankers as demand weakness persists. The analyst does not have a price target for Navios Acquisition shares. His favorite names among the Oil Tankers are Ardmore Shipping (ASC), TEN, Ltd. (TNP) and International Seaways (INSW).

TODAY'S FREE FLY STORIES

UDR

UDR, Inc.

09:37
10/21/18
10/21
09:37
10/21/18
09:37
Downgrade
UDR, Inc. rating change  »

UDR, Inc. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

AVB

AvalonBay

$178.01

1.725 (0.98%)

09:37
10/21/18
10/21
09:37
10/21/18
09:37
Downgrade
AvalonBay rating change  »

AvalonBay downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, ALXN

Alexion

$125.96

-0.63 (-0.50%)

04:55
10/21/18
10/21
04:55
10/21/18
04:55
Conference/Events
The ACR and ARHP to hold annual meeting »

American College of…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

AMGN

Amgen

$201.75

-1.03 (-0.51%)

AUPH

Aurinia Pharmaceuticals

$5.56

-0.13 (-2.28%)

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

CELG

Celgene

$82.42

-0.52 (-0.63%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FLXN

Flexion

$18.96

0.33 (1.77%)

GILD

Gilead

$73.27

-0.9 (-1.21%)

GSK

GlaxoSmithKline

$40.87

1.25 (3.16%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

RARE

Ultragenyx

$63.33

-0.77 (-1.20%)

QDEL

Quidel

$64.68

-2.85 (-4.22%)

PFE

Pfizer

$44.50

0.48 (1.09%)

NVS

Novartis

$87.19

0.95 (1.10%)

MRK

Merck

$72.34

0.12 (0.17%)

MCK

McKesson

$132.36

-0.34 (-0.26%)

LLY

Eli Lilly

$111.91

-1.4 (-1.24%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SELB

Selecta Biosciences

$13.80

-1.34 (-8.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 09

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

  • 28

    Apr

  • 13

    May

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, DCPH

Deciphera

$22.22

-4.97 (-18.28%)

04:55
10/21/18
10/21
04:55
10/21/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO 2018 Congress to be…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

DCPH

Deciphera

$22.22

-4.97 (-18.28%)

TSRO

Tesaro

$41.81

-1.19 (-2.77%)

IMGN

ImmunoGen

$7.44

-0.355 (-4.56%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

CRSP

Crispr Therapeutics

$36.02

-1.18 (-3.17%)

CLVS

Clovis

$26.41

-3.54 (-11.82%)

MRTX

Mirati Therapeutics

$40.04

-1.82 (-4.35%)

LOXO

Loxo Oncology

$160.01

-7.58 (-4.52%)

RHHBY

Roche

$0.00

(0.00%)

NCNA

NuCana

$18.90

1.9 (11.18%)

CRVS

Corvus Pharmaceuticals

$8.01

-0.1 (-1.23%)

NTGN

Neon Therapeutics

$8.88

0.56 (6.73%)

NKTR

Nektar

$48.23

-1.33 (-2.68%)

EXEL

Exelixis

$16.27

-0.25 (-1.51%)

AVEO

Aveo Pharmaceuticals

$2.50

-0.03 (-1.19%)

KURA

Kura Oncology

$14.38

-1.18 (-7.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 10

    Nov

  • 26

    Nov

  • 27

    Nov

  • 24

    Dec

  • 14

    Jan

  • 28

    Apr

  • 13

    May

04:55
10/21/18
10/21
04:55
10/21/18
04:55
Conference/Events
Morgan Stanley China hardware analyst to hold analyst/industry conference call »

China Hardware Tech…

BIIB

Biogen

$319.85

-10.4 (-3.15%)

14:57
10/20/18
10/20
14:57
10/20/18
14:57
Conference/Events
Biogen to host conference call »

Chief Medical Officer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

SELB

Selecta Biosciences

$13.80

-1.34 (-8.85%)

14:13
10/20/18
10/20
14:13
10/20/18
14:13
Conference/Events
Selecta Biosciences to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

TROV

Trovagene

$1.12

-0.03 (-2.61%)

14:11
10/20/18
10/20
14:11
10/20/18
14:11
Conference/Events
Trovagene to host conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLS

Sellas Life Sciences

$1.56

-0.24 (-13.33%)

13:54
10/20/18
10/20
13:54
10/20/18
13:54
Conference/Events
Sellas Life Sciences to host conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 07

    Nov

NVS

Novartis

$87.19

0.95 (1.10%)

13:50
10/20/18
10/20
13:50
10/20/18
13:50
Conference/Events
Novartis to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 07

    Nov

UA

Under Armour

$16.79

-0.365 (-2.13%)

, UAA

Under Armour

$18.20

-0.42 (-2.26%)

12:43
10/20/18
10/20
12:43
10/20/18
12:43
Periodicals
Under Armour stock could triple, Barron's says »

Under Armour has had a…

UA

Under Armour

$16.79

-0.365 (-2.13%)

UAA

Under Armour

$18.20

-0.42 (-2.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 30

    Oct

  • 27

    Nov

  • 03

    Mar

STZ

Constellation Brands

$222.98

-2.36 (-1.05%)

, CGC

Canopy Growth

$46.87

-1.99 (-4.07%)

12:37
10/20/18
10/20
12:37
10/20/18
12:37
Periodicals
Constellation Brands changing CEOs, not marijuana strategy, Barron's says »

Constellation Brands…

STZ

Constellation Brands

$222.98

-2.36 (-1.05%)

CGC

Canopy Growth

$46.87

-1.99 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 14

    Nov

CFG

Citizens Financial

$36.36

1.44 (4.12%)

, AAPL

Apple

$219.28

3.3 (1.53%)

12:33
10/20/18
10/20
12:33
10/20/18
12:33
Periodicals
Citizens Financial stock worth buying, Barron's says »

Citizens Financial (CFG)…

CFG

Citizens Financial

$36.36

1.44 (4.12%)

AAPL

Apple

$219.28

3.3 (1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.95

-1 (-0.65%)

, AAPL

Apple

$219.28

3.3 (1.53%)

12:26
10/20/18
10/20
12:26
10/20/18
12:26
Periodicals
Netflix emerged as winner in new way to rank big tech stocks risk, Barron's says »

A year ago,…

FB

Facebook

$153.95

-1 (-0.65%)

AAPL

Apple

$219.28

3.3 (1.53%)

AMZN

Amazon.com

$1,763.91

-7.54 (-0.43%)

NFLX

Netflix

$332.69

-14.02 (-4.04%)

GOOG

Alphabet

$1,096.41

8.51 (0.78%)

GOOGL

Alphabet Class A

$1,104.66

7.43 (0.68%)

DIS

Disney

$118.81

2.55 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 03

    Mar

BABA

Alibaba

$142.90

1.1 (0.78%)

, TCEHY

Tencent

$0.00

(0.00%)

12:17
10/20/18
10/20
12:17
10/20/18
12:17
Periodicals
Chinese internet giants down, not out, Barron's says »

Alibaba (BABA), Tencent…

BABA

Alibaba

$142.90

1.1 (0.78%)

TCEHY

Tencent

$0.00

(0.00%)

BIDU

Baidu

$191.93

0.1 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 02

    Nov

BLK

BlackRock

$401.61

1.74 (0.44%)

, IVZ

Invesco

$22.00

0.74 (3.48%)

12:13
10/20/18
10/20
12:13
10/20/18
12:13
Periodicals
Fund companies sued by own employees over pricey 401k plans, Barron's says »

BlackRock (BLK),…

BLK

BlackRock

$401.61

1.74 (0.44%)

IVZ

Invesco

$22.00

0.74 (3.48%)

TROW

T. Rowe Price

$100.13

0.31 (0.31%)

SCHW

Charles Schwab

$46.81

0.11 (0.24%)

MTB

M&T Bank

$162.72

2.09 (1.30%)

MS

Morgan Stanley

$46.43

0.4 (0.87%)

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 26

    Feb

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

, BLK

BlackRock

$401.61

1.74 (0.44%)

12:04
10/20/18
10/20
12:04
10/20/18
12:04
Periodicals
Khashoggi case puts financial ties to Saudis under strain, Barron's says »

The suspected killing of…

JPM

JPMorgan

$107.92

-0.21 (-0.19%)

BLK

BlackRock

$401.61

1.74 (0.44%)

BX

Blackstone

$34.66

-0.61 (-1.73%)

AMC

AMC Entertainment

$19.81

0.18 (0.92%)

IMAX

Imax

$22.45

-0.11 (-0.49%)

SIX

Six Flags

$66.40

-1.16 (-1.72%)

WWE

WWE

$82.02

-1.49 (-1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 13

    Nov

  • 14

    Nov

  • 26

    Feb

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, ALXN

Alexion

$125.96

-0.63 (-0.50%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
The ACR and ARHP to hold annual meeting »

American College of…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

AMGN

Amgen

$201.75

-1.03 (-0.51%)

AUPH

Aurinia Pharmaceuticals

$5.56

-0.13 (-2.28%)

BMY

Bristol-Myers

$54.31

-1.7 (-3.04%)

CELG

Celgene

$82.42

-0.52 (-0.63%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FLXN

Flexion

$18.96

0.33 (1.77%)

GILD

Gilead

$73.27

-0.9 (-1.21%)

GSK

GlaxoSmithKline

$40.87

1.25 (3.16%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

RARE

Ultragenyx

$63.33

-0.77 (-1.20%)

QDEL

Quidel

$64.68

-2.85 (-4.22%)

PFE

Pfizer

$44.50

0.48 (1.09%)

NVS

Novartis

$87.19

0.95 (1.10%)

MRK

Merck

$72.34

0.12 (0.17%)

MCK

McKesson

$132.36

-0.34 (-0.26%)

LLY

Eli Lilly

$111.91

-1.4 (-1.24%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SELB

Selecta Biosciences

$13.80

-1.34 (-8.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 09

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

  • 18

    Feb

  • 28

    Apr

  • 13

    May

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

, DCPH

Deciphera

$22.22

-4.97 (-18.28%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO 2018 Congress to be…

ABBV

AbbVie

$88.01

-1.93 (-2.15%)

DCPH

Deciphera

$22.22

-4.97 (-18.28%)

TSRO

Tesaro

$41.81

-1.19 (-2.77%)

IMGN

ImmunoGen

$7.44

-0.355 (-4.56%)

REGN

Regeneron

$389.94

-5.45 (-1.38%)

CRSP

Crispr Therapeutics

$36.02

-1.18 (-3.17%)

CLVS

Clovis

$26.41

-3.54 (-11.82%)

MRTX

Mirati Therapeutics

$40.04

-1.82 (-4.35%)

LOXO

Loxo Oncology

$160.01

-7.58 (-4.52%)

RHHBY

Roche

$0.00

(0.00%)

NCNA

NuCana

$18.90

1.9 (11.18%)

CRVS

Corvus Pharmaceuticals

$8.01

-0.1 (-1.23%)

NTGN

Neon Therapeutics

$8.88

0.56 (6.73%)

NKTR

Nektar

$48.23

-1.33 (-2.68%)

EXEL

Exelixis

$16.27

-0.25 (-1.51%)

AVEO

Aveo Pharmaceuticals

$2.50

-0.03 (-1.19%)

KURA

Kura Oncology

$14.38

-1.18 (-7.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 20

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 28

    Oct

  • 30

    Oct

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 06

    Nov

  • 07

    Nov

  • 10

    Nov

  • 26

    Nov

  • 27

    Nov

  • 24

    Dec

  • 14

    Jan

  • 28

    Apr

  • 13

    May

A

Agilent

$64.47

-1.28 (-1.95%)

, AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

04:55
10/20/18
10/20
04:55
10/20/18
04:55
Conference/Events
American Society of Human Genetics to hold a conference »

ASHG Conference 2018 will…

A

Agilent

$64.47

-1.28 (-1.95%)

AGLE

Aeglea BioTherapeutics

$9.32

-0.58 (-5.86%)

ALXN

Alexion

$125.96

-0.63 (-0.50%)

RHHBY

Roche

$0.00

(0.00%)

BMRN

BioMarin

$103.31

-0.52 (-0.50%)

BIO

Bio-Rad

$280.96

-3.23 (-1.14%)

MSFT

Microsoft

$108.55

0.01 (0.01%)

ILMN

Illumina

$313.31

-7.98 (-2.48%)

FLDM

Fluidigm

$7.49

-0.45 (-5.67%)

HZNP

Horizon Pharma

$19.07

-0.01 (-0.05%)

NVTA

Invitae

$12.86

-0.23 (-1.76%)

NSTG

NanoString

$15.18

-0.41 (-2.63%)

QGEN

Qiagen

$35.91

0.455 (1.28%)

DGX

Quest Diagnostics

$102.49

0.12 (0.12%)

RTRX

Retrophin

$25.34

0.24 (0.96%)

TMO

Thermo Fisher

$227.13

-2.51 (-1.09%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

ARQL

ArQule

$4.33

-0.38 (-8.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 21

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 13

    Nov

  • 27

    Nov

  • 28

    Nov

  • 24

    Dec

  • 18

    Feb

  • 03

    Mar

CLBR

Caliburn International

$0.00

(0.00%)

18:27
10/19/18
10/19
18:27
10/19/18
18:27
Syndicate
Caliburn International files registration statement for proposed IPO »

Caliburn International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

18:10
10/19/18
10/19
18:10
10/19/18
18:10
General news
Saudi Arabia says Kashoggi killed after fight broke out in consulate, CNBC says 

Reference Link

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$276.21

-0.12 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$99.62

2.61 (2.69%)

18:02
10/19/18
10/19
18:02
10/19/18
18:02
Hot Stocks
Celanese raises prices on MIBK, MIBC by EUR120/MT in Europe »

Celanese announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

REGN

Regeneron

$389.94

-5.45 (-1.38%)

, SNY

Sanofi

$44.57

0.12 (0.27%)

17:57
10/19/18
10/19
17:57
10/19/18
17:57
Hot Stocks
Regeneron, Sanofi: FDA approves asthma indication for Dupixent »

Regeneron Pharmaceuticals…

REGN

Regeneron

$389.94

-5.45 (-1.38%)

SNY

Sanofi

$44.57

0.12 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

, XLU

Utilities SPDR

$54.57

0.82 (1.53%)

17:55
10/19/18
10/19
17:55
10/19/18
17:55
General news
Week ending ETF Scorecard: Staples, Real Estate, Utilities lead rebound »

S&P500 SECTORS: …

XLE

Energy Select Sector SPDR

$71.50

-0.67 (-0.93%)

XLU

Utilities SPDR

$54.57

0.82 (1.53%)

IYR

DJ US Real Estate Index Fund

$77.83

0.63 (0.82%)

XLP

Consumer Staples Sector SPDR

$54.72

1.225 (2.29%)

XLY

Consumer Discretionary Sector SPDR

$106.34

-1.06 (-0.99%)

XLB

S&P Select Materials SPDR

$53.13

-0.36 (-0.67%)

XLF

Financial Select Sector

$26.66

0.08 (0.30%)

XLV

Health Care Select Sector SPDR

$91.48

-0.93 (-1.01%)

XLK

Technology Select Sector SPDR

$70.00

-0.04 (-0.06%)

XLI

Industrial Select Sector SPDR

$73.17

-0.31 (-0.42%)

GLD

SPDR Gold Trust

$116.01

0.11 (0.09%)

SLV

iShares Silver Trust

$13.74

0.05 (0.37%)

USO

United States Oil Fund

$14.72

0.155 (1.06%)

UNG

United States Natural Gas Fund

$26.81

0.19 (0.71%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$84.90

0.04 (0.05%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$112.69

-0.15 (-0.13%)

TLT

iShares 20+ Year Treasury Bond Fund

$113.73

-0.24 (-0.21%)

IEF

iShares 7-10 Year Treasury Bond ETF

$100.12

-0.12 (-0.12%)

SHY

iShares 1-3 Year Treasury Bond

$82.95

-0.035 (-0.04%)

IWD

iShares Russell 1000 Value

$122.17

0.08 (0.07%)

IWF

iShares Russell 1000 Growth

$145.19

-0.5 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.